Research, Select, & Monitor Friday, February 15, 2019 10:09:28 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Neogen Corp.$62.99$.42.67%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Neogen Corp. vs Diagnostic Substances

Neogen Corporation develops, manufactures, and markets a diverse line of products dedicated to food and animal safety. The company's food safety segment consists primarily of diagnostic test kits and related products, including dehydrated culture media, marketed to food producers and processors to aid in the detection of foodborne bacteria, natural toxins, food allergens, drug residues, pesticide residues, plant disease infections and levels of general sanitation.

Be they in the hardware development side or the chemical development side, these companies have the same goal; to increase the disease detection threshold and to increase the productivity of labs so more tests can be performed in less time. Each company tends to go about this goal in a different way. One company is involved heavily in gene testing and therapy, another is in manufacturing better isotopes to be used in nuclear medicine. Also, some companies have their hand in the home-testing fields for such things as Human Immunodeficiency Virus (HIV, the virus that causes AIDS) and other diseases.
 Totals Company Industry
  Sales: $402.3 Mil $6,819.1 Mil
  Market Cap: $3,290.6 Mil $87,531.8 Mil
  Analysts Recommendation: Hold Buy

 Averages Company Industry
  Historic Revenue: 11.2% (1.7%)
  Estimated Revenue: 5.8% (1.3%)
  Historic Earnings: 40.7% 20.5%
  Estimated Earnings: 2.9% 7.3%
  Stock Price (1 Year): 8.8% 101.0%
  Cash per Share: 5.5% 68.5%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 49.2 88.9
  Price-to-Sales: 8.0 N/A
  Price-to-Book: 5.8 (189.0)
  Dividend Yield: N/A N/A
  Market Cap: $3,290.6 Mil $4,376.6 Mil
  Net Margin: 15.9% (1,713.8%)
  Gross Margin: 47.3% 51.0%
  Return on Equity: .1 (.2)
  Return on Assets: .1 (.1)
  Balance Sheet
  Current Ratio: 9.7 5.6
  Quick Ratio: 7.7 5.0
  Cash Ratio: 5.4 4.2
  Debt-to-Equity: .1 .5
  Interest Coverage: N/A (1.4)
  Relative-Strength Index: 64.1 N/A

 Other companies in Diagnostic Substances Price Market Cap
  Edwards Lifesciences Corp.  (EW) $177.78 $36,817.9 Mil
  IDEXX Laboratories, Inc.  (IDXX) $210.26 $17,844.4 Mil
  DexCom Inc  (DXCM) $148.49 $13,133.2 Mil
  Wright Medical Group Inc.  (WMGI) $31.87 $3,921.3 Mil
  NuVasive Inc.  (NUVA) $58.59 $3,008.1 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.